Prescription drug · ANDA
Methenamine Hippurate NDC 59746-797
Methenamine hippurate 1 g/1 · Tablet · Oral · Jubilant Cadista Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 59746-797-01 | 5974607970159746079701 | 100 TABLET in 1 BOTTLE (59746-797-01)Marketed from Jan 24, 2023 | |
| 59746-797-65 | 5974607976559746079765 | 20 TABLET in 1 BOTTLE (59746-797-65)Marketed from Jan 24, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Methenamine Hippurate
- Generic name (nonproprietary)
- methenamine hippurate
- Active ingredients
- Methenamine hippurate — 1 g/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Jubilant Cadista Pharmaceuticals Inc.NDC labeler code 59746
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 217675
- Marketing start
- Listing expires
- Identifiers
- Product ID 59746-797_66ecc892-3ddf-4fc3-b58d-ce1d3581ea2cSPL ID 66ecc892-3ddf-4fc3-b58d-ce1d3581ea2cSPL set ID 4263d826-7de2-4011-b8ec-ba1f5222f0e6RxCUI 992150UNII M329791L57UPC 0359746797010
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N459746079701followed by a unit qualifier and the quantityPackage 59746-0797-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS Methenamine hippurate tablets, USP is indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections when long-term therapy is considered necessary. This drug should only be used after eradication of the infection by other appropriate antimicrobial agents. To reduce the development of drug-resistant bacteria and maintain the effectiveness of methenamine hippurate tablets, USP and other antibacterial drugs, methenamine hippurate tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be cons…
Excerpt only. Read the full label for complete information.
About NDC 59746-797
- What is NDC 59746-797?
- 59746-797 is the product NDC for Methenamine Hippurate, Methenamine hippurate 1 g/1 tablet, listed with the FDA by Jubilant Cadista Pharmaceuticals Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Methenamine Hippurate.
- What is the active ingredient?
- Methenamine hippurate.
- Who is the labeler?
- Jubilant Cadista Pharmaceuticals Inc., NDC labeler code 59746. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Methenamine Hippurate?
- 11 other product NDCs are listed under this name. See all Methenamine Hippurate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Methenamine Hippurate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Methenamine Hippurate | Methenamine hippurate 1 g/1 | TabletOral | ANI Pharmaceuticals, Inc. | 70954-959 | 70954-0959-10 |
| Methenamine Hippurate | Methenamine hippurate 1 g/1 | TabletOral | NorthStar Rx LLC | 72603-816 | 72603-0816-01 |
| Methenamine hippurate | Methenamine hippurate 1 g/1 | TabletOral | Zydus Lifesciences Limited | 70771-1919 | 70771-1919-01 |
| Methenamine hippurate | Methenamine hippurate 1 g/1 | TabletOral | Viona Pharmaceuticals Inc | 72578-175 | 72578-0175-01 |
| Methenamine Hippurate | Methenamine hippurate 1000 mg/1 | TabletOral | American Health Packaging | 60687-694 | 60687-0694-21 |
| Methenamine Hippurate | Methenamine hippurate 1 g/1 | TabletOral | Ingenus Pharmaceuticals, LLC | 50742-142 | 50742-0142-01 |
| Methenamine Hippurate | Methenamine hippurate 1000 mg/1 | TabletOral | AvPAK | 50268-549 | 50268-0549-15 |
| Methenamine Hippurate | Methenamine hippurate 1 g/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-880 | 51407-0880-01 |
| Methenamine Hippurate | Methenamine hippurate 1000 mg/1 | TabletOral | Micro Labs Limited | 42571-332 | 42571-0332-0142571-0332-23 |
| Methenamine Hippurate | Methenamine hippurate 1 g/1 | TabletOral | Aurobindo Pharma Limited | 65862-782 | 65862-0782-01 |